SRRK Stock Analysis Today
Updated Nov 7, 2026 · trends, key levels, insider activity and news
Is SRRK bullish or bearish today?
Daily trend: Downtrend (starting) — turns up above $61.76
SEPT signal: Institutional Drive · Consolidating
Research grade: B+ · fair value $37.45 (+49.1%)
SRRK trend by timeframe
| Daily | Downtrend (starting) |
|---|---|
| 4 hour | Symmetric Triangle |
| 1 hour | Strong Bullish |
| 15 min | Leaning Bearish |
| 5 min | Consolidating |
Trends are calculated from price structure and update during market hours.
SRRK support and resistance levels
Resistance (above)
$47.277 touches
$51.737 touches
$53.862 touches
Support (below)
$45.199 touches
$42.8911 touches
$40.764 touches
Upside zones: $44.14 / $44.59 / $45.04
See all levels on the live chart →Insider and institutional activity
Insiders
Buy30-day buys / sells
6 / 030-day net
$12.0MHedge fund holders
263Latest SRRK news and filings
- NewsFiscal.ai
Scholar Rock Insider Buys $12 Million in Company Shares
An insider at Scholar Rock purchased $12 million worth of the company's shares. The filing shows a large buy by a company insider.
- SEC FilingSECScholar Rock Holding Corp filed an insider trading report (Form 4)
Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.
- LegalBenzinga
Scholar Rock Gets FDA Priority Review Voucher for Isembyld
Scholar Rock has received a priority review voucher from the FDA for its drug Isembyld. This voucher can speed up future regulatory reviews.
- LegalBenzinga
Scholar Rock refiles EMA application for apitegromab in spinal muscular atrophy
Scholar Rock has submitted its marketing authorisation application to the EMA again for apitegromab, a treatment intended for pediatric and grown patients living with spinal muscular atrophy.
- EarningsBenzinga
Scholar Rock Holding Posts Second-Quarter 2026 Financial Results
The company disclosed its financial performance for the April-to-June period of 2026. A conference call accompanied the release of those figures.
- AnalystBenzinga
Truist Securities keeps Buy rating on Scholar Rock Holding, lifts target to $77
Truist Securities reiterated its Buy rating on Scholar Rock Holding and raised its price target to $77. The update reflects the firm's revised view of the stock.
- AnalystBenzinga
JP Morgan keeps Overweight on Scholar Rock, lifts target to $70
JP Morgan reiterated its Overweight rating on Scholar Rock Holding and raised its price target to $70. The update reflects the firm's current view on the stock.
- AnalystBenzinga
Evercore ISI keeps Outperform on Scholar Rock, lifts target to $72
Evercore ISI Group reiterated its Outperform rating on Scholar Rock Holding and raised its price target to $72. The update reflects the firm's latest view on the stock.
Live SRRK chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is SRRK bullish or bearish today?
SRRK daily trend: Downtrend (starting) — turns up above $61.76. SEPT signal: Institutional Drive (Consolidating). Updated Nov 7, 2026.
What is SRRK's trend on each timeframe?
Daily: Downtrend (starting); 4 hour: Symmetric Triangle; 1 hour: Strong Bullish; 15 min: Leaning Bearish; 5 min: Consolidating.
What are SRRK support and resistance levels?
Support: $45.19, $42.89, $40.76. Resistance: $47.27, $51.73, $53.86. Last price $46.94.
Are insiders buying or selling SRRK?
Insider signal: Buy. Last 30 days: 6 buys, 0 sells, net $12.0M. 263 hedge funds hold SRRK.
What is the latest news on SRRK?
Oct 28, 2026: Scholar Rock Insider Buys $12 Million in Company Shares · Oct 27, 2026: Scholar Rock Holding Corp filed an insider trading report (Form 4) · Oct 23, 2026: Scholar Rock Gets FDA Priority Review Voucher for Isembyld